ArticlePDF Available

Bilateral Numerous Warts in Upper and Lower Eyelids, in Middle-Aged Man

Authors:
Journal of Clinical Research and Ophthalmology
eertechz
Citation: Davari MH, Gheytasi H (2015) Bilateral Numerous Warts in Upper and Lower Eyelids, in Middle-Aged Man. J Clin Res Ophthalmol 2(3): 031-032.
DOI: 10.17352/2455-1414.000016
031
Abstract
Background: Warts are small, usually painless growths on the skin caused by a virus called
human papillomavirus (HPV). Most, but not all, are generally harmless [1,2].
Warts can be disguring and embarrassing. Sometimes they itch or hurt (particularly on the feet).
Some warts spread through sex. But in The eyelids are rare. Viral warts are a common skin condition,
which can range in severity from a minor nuisance that resolve spontaneously to a troublesome,
chronic condition [3-5]. Many different treatments are available but because warts were very large, we
use a surgical procedure (excision).
Purpose: To evaluate the efcacy of cut out the wart (excision) by surgery.
Materials/Patients: In this case report, 56 years old man have been reported with upper and
lower eyelid involvement in both eyes. Expressed warts came the age of 20 and around the eyelids
of both eyes and then grows within 5 years, Sized warts at presentation were 1 to 5 mm until warts
on eyelids make adverse effects on vision. Warts were also seen around the patient’s neck. He had
no other illnesses. The patient’s mother had two warts 4 to 5 mm around her nose. We have treated
the warts eye in vali Asr hospital, Birjand University of Medical Sciences. Pathologist also reported
Verruca Vulgarism. Patient after surgery was visit in terms of recurrence and fortunately it was not a
problem.
Case Report
Bilateral Numerous Warts in Upper
and Lower Eyelids, in Middle-Aged
Man
Discussion
Common warts can be annoying to anyone. It is worth considering
that, in normal people, half of all warts, on average, spontaneously go
away within about 18 months.
We have treated the warts eye in vali Asr hospital, Birjand
University of Medical Sciences. Because the location and number
of warts around the eyes were large, other treatments are not
appropriate, so we chose a surgical procedure. Despite of more
treatments about warts including: Cryotherapy, cantharidin, Electro
surgery and curettage, Laser, Chemical peels… We use a surgical
procedure because warts were very large (excision).
We cut out the warts with sharp knife completely in local
anesthesia, Pathologist also reported Verruca Vulgarism. Still has not
recurred aer 18 months (Figures 1-6).
Mohammad Hossein Davari1* and
Hoda Gheytasi2
1Birjand Atherosclerosis and Coronary Artery
Research Center, Assistant Professor of
Ophthalmology, Birjand University of Medical
Science, Birjand, Iran
2Department of Genetic, PhD student of genetic
at University of Barcelona translational research,
laboratory2 Hospital Duran I Reynolds
Dates: Received: 19 December, 2014; Accepted:
16 March, 2015; Published: 18 March, 2015
*Corresponding author: Mohammad Hossein
Davari, Ophthalmology Department, Vali Asre
Hospital, Birjand University of Medical Science, South
Khorassan, Ghaffari Street Birjand, Iran, E-mail:
www.peertechz.com
Keywords: Wart; Uper lid; Lower lid
ISSN: 2455-1414
Figure 1:
Figure 2:
Figure 3:
Citation: Davari MH, Gheytasi H (2015) Bilateral Numerous Warts in Upper and Lower Eyelids, in Middle-Aged Man. J Clin Res Ophthalmol 2(3): 031-032.
DOI: 10.17352/2455-1414.000016
Davari and Gheytasi (2015)
032
Conclusion
Conclusion: Bilateral eye lids involvement of multiple warts are
rare but they can oen be treated successfully by surgical incision
without recurrence.
References
1. Warts, herpes simplex, and other viral infections. In: Habif TP, ed. Clinical
Dermatology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2009:chap 12.
2. Myer CM 3rd, Woodruff SM (1983) Pathologic quiz case 2. Squamous
papilloma of the external auditory canal. Arch Otolaryngol 109:200-1, 203.
3. Nager GT (1993) Neoplasms and other lesions of the external ear. In:
Pathology of the ear and temporal bone. Baltimore: Williams & Wilkins 387–
412.
4. Hyams VJ, Batsakis JG, Michaels L (1988) In: Atlas of tumor pathology.
Tumors of the upper respiratory tract and ear. 2nd series. Fascicle25.
Washington DC: AFIP 260–261.
5. Mills SE, Gaffey MJ, Frierson JR (2000) HF. In: Atlas of tumor pathology.
Tumors of the upper aerodigestive tract and ear. 3rd series. Fascicle 26.
Washington DC: AFIP 408–409.
6. Yadav SP, Chandra R, Goyal N (2002)Auralpapillomatosis in a 3-year-old
child. Int J PediatrOtorhinolaryngol66:185–187.
7. Dickson RI, Worth AJ (1978)Malignant squamous papillomatosis of the
mastoid. J Otolaryngol7:283–288.
8. Block SL, Nolan T, Sattler C (2006) Comparison of the immunogenicity and
rectogenicity of prophylactic quadrivalent human papillomavirus (types 6, 11,
16, and 18) L1 virus-like particle vaccine in male and female adolescents and
young adult women. Pediatrics118:2135–2145.
9. Markowitz LE, Dunne EF, Saraiva M (2007)Quadrivalent human
papillomavirus vaccine. Recommendations of the Advisory Committee on
Immunization Practices (ACIP) MMWR Recomm Rep56:1–24.
10. Gibbs S (2006) Topical treatments for cutaneous warts. Cochrane Database
Syst Rev(3):CD001781.
Copyright: © 2015 Davari MH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 4:
Figure 5:
Figure 6:
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of HPV vaccines. Persistent infection with oncogenic HPV types can cause cervical cancer in women as well as other anogenital and oropharyngeal cancers in women and men. HPV also causes genital warts. Two HPV vaccines are licensed in the United States. Both are composed of type-specific HPV L1 protein, the major capsid protein of HPV. Expression of the L1 protein using recombinant DNA technology produces noninfectious virus-like particles (VLPs). Quadrivalent HPV vaccine (HPV4) contains four HPV type-specific VLPs prepared from the L1 proteins of HPV 6, 11, 16, and 18. Bivalent HPV vaccine (HPV2) contains two HPV type-specific VLPs prepared from the L1 proteins of HPV 16 and 18. Both vaccines are administered in a 3-dose series. ACIP recommends routine vaccination with HPV4 or HPV2 for females aged 11 or 12 years and with HPV4 for males aged 11 or 12 years. Vaccination also is recommended for females aged 13 through 26 years and for males aged 13 through 21 years who were not vaccinated previously. Males aged 22 through 26 years may be vaccinated. ACIP recommends vaccination of men who have sex with men and immunocompromised persons (including those with HIV infection) through age 26 years if not previously vaccinated. As a compendium of all current recommendations for use of HPV vaccines, information in this report is intended for use by clinicians, vaccination providers, public health officials, and immunization program personnel as a resource. ACIP recommendations are reviewed periodically and are revised as indicated when new information and data become available.
Article
Full-text available
Prophylactic vaccination of 16- to 23-year-old females with a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine has been shown to prevent type-specific human papillomavirus infection and associated clinical disease. We conducted a noninferiority immunogenicity study to bridge the efficacy findings in young women to preadolescent and adolescent girls and boys, who represent a primary target for human papillomavirus vaccination. We enrolled 506 girls and 510 boys (10-15 years of age) and 513 females (16-23 years of age). Participants were vaccinated on day 1, at month 2, and at month 6, and serology testing was performed on day 1 and at months 3 and 7 on blinded samples. Neutralizing antibody concentrations were determined using type-specific immunoassays and summarized as geometric mean titers and seroconversion rates. Vaccine tolerability also was assessed. By month 7, seroconversion rates were > or = 99% for all 4 human papillomavirus types in each group. By month 7, compared with women, anti-human papilloma virus geometric mean titers in girls or boys were noninferior and were 1.7- to 2.7-fold higher. Most (> 97%) injection-site adverse events were mild to moderate in intensity. Significantly more boys (13.8%) and girls (12.8%) than women (7.3%) reported fevers > or = 37.8 degrees C within 5 days of vaccination. Most (96.4%) fevers were mild (< 39 degrees C). Noninferior immunogenic responses to all 4 human papillomavirus types in the quadrivalent vaccine permit the bridging of efficacy data that were generated in young women to girls. The results in boys lend support for the implementation of gender-neutral human papillomavirus vaccination programs. This vaccine generally was well tolerated.
Article
Benign squamous papilloma of the external ear is rarely reported in the literature. This paper describes the occurrence of an extensive benign squamous papillomatosis of the mastoid that showed an apparent malignant transformation with fatal results to the patient.
Article
A rare case of 3-year-old girl, presenting with aural papillomatosis, was successfully treated by surgical excision with no recurrence thereafter. Main emphasis of surgery was to avoid seeding the lesion and restructuring the external auditory canal.
HF. In: Atlas of tumor pathology. Tumors of the upper aerodigestive tract and ear. 3rd series
  • Mills
  • Se
  • M J Gaffey
  • J R Frierson
Mills SE, Gaffey MJ, Frierson JR (2000) HF. In: Atlas of tumor pathology. Tumors of the upper aerodigestive tract and ear. 3rd series. Fascicle 26. Washington DC: AFIP 408-409.
Topical treatments for cutaneous warts
  • Gibbs
Neoplasms and other lesions of the external ear
  • G T Nager
Nager GT (1993) Neoplasms and other lesions of the external ear. In: Pathology of the ear and temporal bone. Baltimore: Williams & Wilkins 387-412.
Auralpapillomatosis in a 3-year-old child
  • S P Yadav
  • R Chandra
  • N Goyal
Yadav SP, Chandra R, Goyal N (2002)Auralpapillomatosis in a 3-year-old child. Int J PediatrOtorhinolaryngol66:185-187.